RiverVest Venture Partners

RiverVest Venture Partners

RiverVest Venture Partners invests in early-stage life science companies.

RiverVest Venture Partners focuses exclusively on innovations in life sciences, a field in which their team has significant research, clinical, operational and investment expertise. The team's deep domain experience allows them to identify promising investment opportunities, particularly in biopharmaceuticals and medical devices. They provide practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. RiverVest founds and actively incubates life science companies, including through its Archer Seed Fund. The Firm also invests in select later-stage opportunities to diversify risk and maximize portfolio returns. In every case, it takes a hands-on investment approach, preferring to be represented on the boards of their portfolio companies.

Investment

RiverVest Venture Partners' investments include Excaliard Pharmaceuticals, Cabrellis Pharmaceuticals, MacroGenics, Kereos, Velocimed, Auxeris Therapeutics, Salient Surgical Technologies and NexRay.

Their exited investments include Allakos, Mirum Pharmaceuticals, ZS Pharma, Otonomy, MacroGenics, Accumetrics, Lumena Pharmaceuticals, IDEV Technologies, Securus Medical Group and Lutonix.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Genoa Pharmaceuticals

Now Avalyn Pharma, a biopharmaceutical company developing therapies to treat idiopathic pulmonary fibrosis and other respiratory diseases

Biotechnology
San Diego
Otonomy

A biopharmaceutical company focused on developing treatments for inner and middle ear diseases

Biotechnology
San Diego
Allakos

A company that develops therapeutic antibodies to treat diseases and allergies

Biotechnology
San Carlos, California
Amplyx Pharmaceuticals

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.

San Diego
OncoResponse

OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.

Cancer
Seattle
Mirum Pharmaceuticals

Mirum Pharmaceuticals is a Menlo Park, California-based company.

Menlo Park, California
CardiaLen

Scout Bio (Company)

Biotechnology
Arch Oncology

Arch Oncology is a Brisbane, California-based company.

Brisbane, California
InterVene

InterVene is a South San Francisco, California-based company.

South San Francisco, California
10 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
RiverVest Venture Fund III (Ohio), L.P.
4,000,000
4,000,000
Cleveland
March 27, 2015
3x5 RiverVest Fund II, L.P.
125,000,000
St. Louis
November 18, 2015
RiverVest Venture Fund III, L.P.
150,000,000
St. Louis
March 11, 2014
RiverVest Venture Fund IV, L.P.
150,000,000
St. Louis
December 14, 2017
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.